Posted June 10, 2021
By the end of April 2021, about eight percent of those who received the first dose of the experimental mRNA Pfizer/BioNTech or Moderna/NIAID COVID-19 vaccines being distributed under an Emergency Use Authorization (EUA) granted by the U.S. Food and Drug Administration (FDA) had not received the second dose of the vaccines. This represents more than five million people in the United States. Read more.